Bariatric surgery in morbidly obese patients improves the atherogenic qualitative properties of the plasma lipoproteins

Atherosclerosis. 2014 May;234(1):200-5. doi: 10.1016/j.atherosclerosis.2014.02.034. Epub 2014 Mar 14.

Abstract

Objective: The purpose of this study was to evaluate the effect of weight loss induced in morbidly obese subjects by Roux-en-Y gastric bypass bariatric surgery on the atherogenic features of their plasma lipoproteins.

Methods: Twenty-one morbidly obese subjects undergoing bariatric surgery were followed up for up to 1 year after surgery. Plasma and lipoproteins were assayed for chemical composition and lipoprotein-associated phospholipase A2 (Lp-PLA2) activity. Lipoprotein size was assessed by non-denaturing polyacrylamide gradient gel electrophoresis, and oxidised LDL by ELISA. Liver samples were assayed for mRNA abundance of oxidative markers.

Results: Lipid profile analysis revealed a reduction in the plasma concentrations of cholesterol and triglycerides, which were mainly associated with a significant reduction in the plasma concentration of circulating apoB-containing lipoproteins rather than with changes in their relative chemical composition. All patients displayed a pattern A phenotype of LDL subfractions and a relative increase in the antiatherogenic plasma HDL-2 subfraction (>2-fold; P < 0.001). The switch towards predominantly larger HDL particles was due to an increase in their relative cholesteryl ester content. Excess weight loss also led to a significant decrease in the plasma concentration of oxidised LDL (∼-25%; P < 0.01) and in the total Lp-PLA2 activity. Interestingly, the decrease in plasma Lp-PLA2 was mainly attributed to a decrease in the apoB-containing lipoprotein-bound Lp-PLA2.

Conclusion: Our data indicate that the weight loss induced by bariatric surgery ameliorates the atherogenicity of plasma lipoproteins by reducing the apoB-containing Lp-PLA2 activity and oxidised LDL, as well as increasing the HDL-2 subfraction.

Keywords: Bariatric surgery; HDL; Lipoprotein-associated phospholipase A2 (Lp-PLA2); Obesity; Oxidised LDL; Weight loss.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Atherosclerosis / blood*
  • Atherosclerosis / etiology
  • Atherosclerosis / prevention & control*
  • Female
  • Gastric Bypass*
  • Humans
  • Lipoproteins / blood*
  • Lipoproteins / physiology
  • Male
  • Middle Aged
  • Obesity, Morbid / blood*
  • Obesity, Morbid / classification
  • Obesity, Morbid / surgery*
  • Weight Loss*
  • Young Adult

Substances

  • Lipoproteins